Demonstrates effective antibody affinity engineering in immunized mice using machine learning, indicating a more efficient design process.
Advanced antibody discovery and engineering workflows take advantage of the combination of high-throughput screening, deep sequencing and machine learning (ML). Most high-throughput methods, however, lack the resolution to provide absolute affinity values of antibody-antigen interactions, limiting their utility for precise engineering of binding kinetics. In this study, we utilize antibody repertoire data, affinity characterization and ML for antibody affinity engineering. Leveraging natural antibody sequence information from repertoires of immunized mice, we identified and experimentally measured affinities for 35 antigen-specific variants. Supervised ML models trained on these sequences achieved remarkable accuracy in predicting affinity, despite the limited dataset size. We utilized the trained ML model to in silico-design eight synthetic antibody variants, of which seven exhibited the desired affinities. Our study illustrates the potential of this streamlined and efficient approach for precise engineering of the affinity of antibodies while reducing extensive experimental screening.
No takes yet. Share an insight, caveat, or question.
Erlach et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: